Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CLASS ACTION UPDATE for KHC, CVS, WTW and SYNH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

KHC, CVS

NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

The Kraft Heinz Company (NASDAQ: KHC)
Class Period:
May 4, 2017 - February 21, 2019
Lead Plaintiff Deadline: April 25, 2019
Join the action: https://www.zlk.com/pslra-1/the-kraft-heinz-company-loss-form?wire=3

About the lawsuit: Throughout the class period, The Kraft Heinz Company allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) Kraft Heinz had been materially overstating the value of certain of its important product lines; (b) Kraft Heinz’s intangible assets, including goodwill, associated with, at least, its Kraft natural cheese, Oscar Mayer cold cuts, U.S. Refrigerated and Canadian retail businesses were materially impaired; (c) Kraft Heinz had been employing improper accounting policies, procedures, and associated with its procurement function, including, but not limited to, agreements, side agreements, and changes or modifications to its agreements with its vendors; (d) Kraft Heinz had been improperly accounting for the costs of products sold; (e) Kraft Heinz had been operating with material weaknesses in its internal controls over financial reporting, including those controls related to the accounting and disclosure of new accounting standards, its cost of products sold, its procurement function, the impairment of goodwill and the impairment of intangible assets; (f) Kraft Heinz’s operating results were materially misstated and Defendants’ disclosures related thereto were materially false and misleading; (g) Kraft  Heinz’s  financial  statements  contained  material  errors,  were presented in violation of GAAP and were materially false and misleading; (h) the risk factor disclosures in filings Kraft Heinz made with the SEC were materially false and misleading; (i) the MD&A disclosures in filings Kraft Heinz made with the SEC were materially false and misleading; (j) the representations about Kraft Heinz’s disclosure controls and internal control over financial reporting in filings the Company made with the SEC were materially false and misleading; (k) the certifications issued by Defendants Hees, Basilio and Knopf on Kraft Heinz’s disclosure controls and internal controls over financial reporting were materially false and misleading; and (l) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about Kraft Heinz’s then-current business operations and future financial prospects.

To learn more about the The Kraft Heinz Company class action contact jlevi@levikorsinsky.com.

CVS Health Corporation (NYSE: CVS)
Class Period:
May 21, 2015 - February 20, 2019
Lead Plaintiff Deadline: April 26, 2019
Join the action: https://www.zlk.com/pslra-1/cvs-health-corporation-loss-form?wire=3

About the lawsuit: CVS Health Corporation allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (i) CVS Health’s financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with the Omnicare Acquisition; and (ii) as a result, CVS Health’s public statements were materially false and misleading at all relevant times.

To learn more about the CVS Health Corporation class action contact jlevi@levikorsinsky.com.

Weight Watchers International, Inc. (NASDAQ: WTW)
Class Period:
May 4, 2018 - February 26, 2019
Lead Plaintiff Deadline: May 3, 2019
Join the action: https://www.zlk.com/pslra-1/weight-watchers-international-inc-loss-form?wire=3

About the lawsuit: During the class period, Weight Watchers International, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) Weight Watchers was experiencing diminished subscriber demand attributable due to the onslaught of new competing smartphone fitness apps, meal-delivery services, and other tech advances was driving down Weight Watchers’ new subscriber growth and its subscriber retention rates; (b) diminished subscriber growth, when coupled with the much larger number of fourth quarter subscription lapses that Weight Watchers typically experiences, made it highly unlikely that the Company would retain four million subscribers by the end of 2018; (c) Weight Watchers was not on track to grow its subscriber count to five million or to drive annual revenues to more than $2 billion by the end-of-2020; (d) a decreased subscriber count would result in decreased revenues and profits; and (e) as a result, Defendants’ statements about Weight Watchers’ business metrics and financial prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.   

To learn more about the Weight Watchers International, Inc. class action contact jlevi@levikorsinsky.com.

Syneos Health, Inc. (NASDAQ: SYNH)
Class Period:
May 10, 2017 - February 27, 2019
Lead Plaintiff Deadline: April 30, 2019
Join the action: https://www.zlk.com/pslra-1/syneos-health-inc-loss-form?wire=3

About the lawsuit: Throughout the class period, Syneos Health, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Syneos Health’s internal control over financial reporting was inadequate; (2) concerns regarding Syneos Health’s internal control over financial reporting would result in heightened regulatory scrutiny and an SEC investigation into the company’s revenue accounting policies, internal controls and related matters; and (3) as a result, defendants’ statements about Syneos Health’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the Syneos Health, Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today